Full Prescribing Information 1. Indications and Usage for ProAir HFA 1.1 Bronchospasm PROAIR HFA Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease. 1.2 Exercise-Induced Bronchospasm PROAIR HFA...
Proair HFA - Detailed Prescribing InformationDrugs
albuterolproairhfasulfateinhalationaerosol 1 1 2 3 4 5 6 7 8 9 10 11 PROAIR™HFA(ALBUTEROLSULFATE) INHALATIONAEROSOL ForOralInhalationOnly PRESCRIBINGINFORMATION DESCRIPTION TheactiveingredientofPROAIRHFA(albuterolsulfate)InhalationAerosolis albuterolsulfate,aracemicsalt,ofalbuterol.Albuterolsulfateisarelative...
doses of 180 mcg four times daily with placebo, one long-term safety study in children 12 years of age and older, and one single-dose crossover study comparing doses of 90 and 180 mcg with albuterol sulfate inhalation aerosol (ProAir® HFA) in 71 patients [see Clinical Studies (14.1)...
The safety of ProAir Digihaler in children 4 to 11 years of age is based on two single-dose, controlled, crossover studies: one with 61 patients comparing doses of 90 and 180 mcg with matched placebo and albuterol HFA MDI and one with 15 patients comparing a dose of 180 mcg with match...
The safety of PROAIR RESPICLICK in children 4 to 11 years of age is based on two single-dose, controlled, crossover studies: one with 61 patients comparing doses of 90 and 180 mcg with matched placebo and albuterol HFA MDI and one with 15 patients comparing a dose of 180 mcg with matc...